Followers | 125 |
Posts | 5428 |
Boards Moderated | 0 |
Alias Born | 06/09/2020 |
![](https://investorshub.advfn.com/uicon/747853.png?cb=1644300972)
Saturday, March 02, 2024 5:15:11 PM
There's RIGHT NOW!
As I have now undisputably shown, the grant from NWBO, is directly traceble to the ATL-DC and poly-iclc trial and the upcoming Nature article.
The puzzle is carved out for you right here, but please do plead ignorance.
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 2, 2024
Autologous tumor lysate–pulsed DC vaccination (DCVax-L) in conjunction with TLR agonists (poly-iclc) was already evaluated for safety in newly diagnosed and recurrent glioblastoma patients in 2010https://t.co/UOMlvQNHPr
Let's follow this rabbit down the hole 💪🏻
This is just ONE of a dozen of pieces of evidence corroborating that fact, but I keep adding to the pile, because paid shills like you DESPERATELY NEED to sow fud about these two combo trials and that DCVax-L is the CENTERPIECE of them.
Oh and by the way.
Robert Prins newest video regarding the SPORE 1 combo trial with DCVax-L and Keytruda.
Robert Prins
![](http://i.postimg.cc/P5PKPqm1/IMG-0899.jpg)
You are also gonna love the image of most of the team behind the DCVax-L and poly-iclc trial and coming Nature article.
![](http://i.postimg.cc/BZBmzkSP/IMG-0897.jpg)
And this image Robert Prins has reused ...
![](http://i.postimg.cc/Dyfx360j/IMG-0898.jpg)
... from Linda Liaus presentations earlier on about the SPORE 1 project here
insert-text-here
Oh and btw.
JUST ONE piece of information. From UCLA Health. A fabulous article which you will hate.
Upper Left Corner: The SPORE 1 Project
The combo trial with DCVax-L + Keytruda (anti-PD-1) and CSF1R inhibition
DCVax-L .... BAAAAM
![](http://i.postimg.cc/qBN8sFtd/IMG-0921.jpg)
And zooming in .... for your viewing pleasure
![](http://i.postimg.cc/Th82g1Kh/IMG-0920.jpg)
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM